Background and Format: Launched in 2003, Medical News Today is a website overseen by Healthline Media UK Ltd and is aimed at healthcare professionals and consumers. Covers health news, diseases, nutrition & diet and pain & aesthetics. For more information about advertising rates, the team can be reached here. Circulation: Source: Publisher.

ASH Clinical News is a news publication from the American Society of Hematology and serves as a source for worldwide news and perspectives on hematology and oncology. Coverage includes blood disorders and related topics of interest to hematologists, including developments in oncology, endocrinology and cardiology. Each month it provides the latest updates in the field along with perspectives and opinions from key leaders as well as tools and resources to help clinicians with quality and performance improvement, patient education, and the economics of running a practice.

Launched in 1855, The Daily Telegraph is published by the Telegraph Media Group Limited daily and is aimed at readers nationwide. Covers news, lifestyle, sport, travel, culture, business., women, men, food & drink, technology, motoring, education, fashion, money, film, luxury and jobs. It also has a sister newspaper, The Sunday Telegraph.

Geared toward practicing ophthalmologists, residents and staff members in office and hospital-based practices, as well as medical teaching and research professionals. Includes clinical studies, patient care information and practice management topics. Offers the latest news on ophthalmic surgery techniques and research in the field while also addressing issues such as managed care and its effect on the industry.

Impact factor: 4.411 (Thomson Reuters, 2016) Journal Ranking: 48/213  (Oncology) (Thomson Reuters, 2016) Affiliations: Blood Cancer Journal is a sister journal to Leukemia. Aims of the journal: Blood Cancer Journal is a peer-reviewed, online, open access, sister journal to Leukemia. The journal aims to bring the fore outstanding pre-clinical and clinical research in the field of hematology, with ramifications into translational biology research down to new therapies. Contents: Topics of particular concentration will include, but are not limited to, the following: Careful analysis of validation of in-vitro experimentations of new compounds devoted to phase 1 studies Murine models Therapies such as specific inhibitory molecules, antibodies, immunotherapy manipulations Editorial contacts: Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the editorial office at bcj@nature.com Manuscript Submission: Instructions for Authors can be found here. Online submission at http://mts-bcj.nature.com/cgi-bin/main.plex